MBSR for Pain Catastrophizing in SCD
NCT02394587 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2017-12-29
Summary
Significance: The purpose of this exploratory study is to test the feasibility, accessibility, and effects of a mindfulness-based stress reduction program (MBSR) on reducing pain catastrophizing in persons with sickle cell disease (SCD) and chronic pain. One of the most difficult symptoms for SCD patients to manage is chronic pain. Approximately one-third of SCD patients experience chronic pain, which is associated with pain catastrophizing. Pain catastrophizing is a negative mental state toward pain stimuli and pain experience, and is associated with increased pain severity, pain interference, and lower social functioning, physical functioning, and mental health. There have been no psychobehavioral intervention studies that have attempted to alter the experience of pain catastrophizing in persons with SCD. MBSR is a complementary group-based therapy that emphasizes nonjudgmental awareness of thoughts, feelings, and bodily sensations. With no pharmacological or non-pharmacological treatment for catastrophizing in persons with SCD, MBSR offers a potential solution to this highly significant problem for both SCD patients and providers. This project will be the first randomized controlled trial (RCT) of MBSR to reduce pain catastrophizing, and improve quality of life for SCD patients with chronic pain.
Methods: This study will enroll 60 adult patients with SCD and chronic pain from the Duke Adult Sickle Cell Clinic. Patients will be randomized to a MBSR or wait-listed control group. The MBSR group will complete a 6- week, group-based telephonic MBSR program that is administered by a certified MBSR clinician once a week for 90 minutes. MBSR feasibility, acceptability, and effects on pain catastrophizing will be assessed by questionnaires at baseline, week 1, 3, and 6 in both groups. At the end of week 6, 10 randomly selected MBSR participants will complete semi-scripted telephone interviews to help assess intervention acceptability, and the wait-listed control condition will be offered the same MBSR intervention.
Conditions
- Anemia, Sickle Cell
Interventions
- BEHAVIORAL
-
Mindfulness-based Stress Reduction
A non-pharmacological approach to pain management.
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Institute of Nursing Research (NINR)
collaborator NIH - lead OTHER
Principal Investigators
-
Paula Tanabe, PhD · Duke University School of Nursing
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- United States
Study Locations
More Related Trials
-
Pain Management Protocol for Pediatric Sickle Cell Disease
NCT00386048 ·Status: COMPLETED
-
Integrative Training Program for Pediatric Sickle Cell Pain
NCT06691867 ·Status: RECRUITING ·Phase: NA
-
A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease
NCT02620488 ·Status: COMPLETED ·Phase: NA
-
Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications
NCT04419168 ·Status: COMPLETED ·Phase: NA
-
Computerized Cognitive Behavioral Therapy Assisted Life Management for Pain in Sickle Cell Disease
NCT03029468 ·Status: COMPLETED ·Phase: NA
-
Use of a Mobile-based App for SCD Patients
NCT01833702 ·Status: COMPLETED
-
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
NCT03049475 ·Status: COMPLETED
-
Ketamine Infusion for Sickle Cell Pain Crisis
NCT04005209 ·Status: WITHDRAWN ·Phase: PHASE4
-
Nitric Oxide and Sickle Cell Pain
NCT01393847 ·Status: TERMINATED
-
Blood Flow and Pain Crises in People With Sickle Cell Disease
NCT01568710 ·Status: COMPLETED
-
Neurovascular Determinants of Cognitive Function in Adults With Sickle Cell Disease
NCT02946905 ·Status: COMPLETED
-
Development and Adaptation of I-STRONG for SCD
NCT06110754 ·Status: COMPLETED ·Phase: NA
-
Transcranial Photobiomodulation Treatment in Patients With Sickle Cell Disease
NCT06797583 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
FOCUS for Pediatric Sickle Cell Disease and Cancer
NCT04075877 ·Status: UNKNOWN ·Phase: NA
-
Codeine in Sickle Cell Disease
NCT00174538 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease
NCT02371720 ·Status: COMPLETED ·Phase: NA
-
Building Adaptive Coping and Knowledge to Improve Daily Life
NCT04602728 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Disease (SCD) Bone Pain Study
NCT05283148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pilot Evaluation of a Motivational Interviewing Intervention Targeting Adherence Behaviors in Youth With Sickle Cell Disease
NCT04877054 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell, Pain and Mediterranean Diet
NCT06886477 ·Status: RECRUITING ·Phase: NA
-
Parent Educational Program for Children With Sickle Cell Disease
NCT00860782 ·Status: COMPLETED ·Phase: NA
-
Pain in Sickle Cell Epidemiologic Study
NCT00035763 ·Status: COMPLETED
-
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease
NCT00528801 ·Status: COMPLETED
-
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study
NCT00850018 ·Status: COMPLETED ·Phase: PHASE1
-
Sickle Cell Improvement: Enhancing Care in the Emergency Department
NCT05373771 ·Status: RECRUITING ·Phase: NA